Newsgroup: it.economia.borsa.estero
Titolo: Porco cane che notizia !!!!!!!! (Biko)

Che news su BIKO !!!!!!!!!!!!!!
Biocontrol Gets $1.5 Million Agreement From U.S. Army
INDIANA, Pa., Sept. 10 /PRNewswire/ -- We have all heard the stories of
people who have fallen through the ice or apparently drown in icy waters
only to be resuscitated with little or no adverse effects.
Now, that cooling process called hypothermia may become a tool to be used by
medical personnel.
Biocontrol Technology, Inc., located in Indiana, PA, a division of
Pittsburgh-based BICO, Inc. (OTC Bulletin Board: BIKO - news), has received
an assistance agreement from the U.S. Army Medical Research Acquisition
Activity in Fort Detrick, MD to develop the hardware for cooling the body.
Dr. Peter Safar of the Safar Center for Resuscitation at the University of
Pittsburgh is conducting research on this phenomenon. The process of quickly
cooling the body to a state of suspended animation is believed to provide an
increased time frame for patients to be transported to a hospital, MASH unit
or other emergency care center. Research at the Safar Center suggests that
the early and rapid induction of mild hypothermia in patients after having
suffered cardiac arrest, brain trauma, or patients in shock can increase the
chance of survival without brain damage.
Rapid introduction of profound hypothermia can extend the period for
resuscitation to an hour or longer in patients who have not been able to be
resuscitated by a standard form of care.
The device that would induce emergency hypothermia has not yet been
developed. This one-year agreement, which is worth over $1.5 million, will
allow Biocontrol to develop the required prototype devices for continued
laboratory research. Biocontrol and the Safar Center will then refine the
devices for clinical trials. This award covers the first year of a proposed
three-year program.
Dr. Safar, founder of the Center for Resuscitation Research in Pittsburgh,
and his research team have been working on resuscitation methods for many
years. He successfully co-developed and introduced cardiopulmonary cerebral
resuscitation (CPCR) methods for reviving victims of trauma or cardiac
arrest starting in the 1950s. He has conducted several clinical studies in
humans and animals.
Biocontrol Technology has had previous success in temperature altering
technology used in medical care. The Indiana, PA firm makes the
ThermoChem(TM) HT-1000 system for its sister company, ViaCirq, Inc. The
ThermoChem device utilizes hyperthermia, or heating of the body, in the
treatment of some forms of cancer. The device recently received approval by
the FDA to be marketed in the U.S. and thus far is being used in hospitals
like the Wake Forest University Baptist Medical Center and Zale Lipshy
University Hospital, a private teaching hospital for the University of Texas
Southwestern Medical Center at Dallas.
BICO, Inc. has its corporate offices in Pittsburgh and is involved in the
development and manufacture of biomedical devices and environmental
solutions.

 ha scritto nel messaggio
news:9nicoc$u27$1...@news.flashnet.it...



Secondo me è ancora presto, ma nulla è da escludere !!!
Anche se 1$ potrebbe essere un po' pochino IMHO.
Questo è un titolo da tenere sul lungo.
Ci sono troppe cose in ballo in questo momento: questa news, il rapid test
per l' HIV, l'attesa della FDA per le varie approvazioni etcc.....
Vedremo :))
22/7

 ha scritto nel messaggio
news:9nihpv$uhf$1...@news.flashnet.it...


 VA A 1000$ caro pi greco ( mi zio e' un adetto della BIKO )
Grazie mille della dritta Franco !!!
:)))
Mmmh, dunque fammi fare due conticini,................
.....se vanno a 1000$, calcolando SPLIT e simili, dovrei riuscire dopo ad
acquisire almeno il 51% di Fiat e Microsoft.
Bene bene !!!
Aspetterò !!!!
Grazie Franco,
22/7
:))))))
(°__°)

 Aspetterň !!!!
